Skip to main content

Advertisement

SpringerLink
Log in

Polio Eradication in India

  • Review
  • Published:
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences Aims and scope Submit manuscript

Abstract

The Global Polio Eradication Initiative gained a great success in India in the last one year, especially on the epidemiology of type 1 wild poliovirus (WPV), by the intensive use of monovalent oral polio vaccine (OPV) type 1. However, failure to completely interrupt the transmission of type 1 and persistence of type 3 WPV in western Uttar Pradesh and Bihar are still causes of concern. The year 2010 was very crucial for polio eradication in India; as good control over transmission of type 1 wild polio virus was achieved. While mOPV1 is a sharper tool against WPV1, bOPV seems to be adequate against WPV3; hence there may not be any more need for mOPV3. Thus, the key to success lies in intelligent and imaginative use of the three OPVs, i.e. mOPV1, bOPV and tOPV, against WPV types 1 and 3, and circulating vaccine derived polio virus types 1, 2 and 3. Serious consideration should be given to a contingency plan to the use of inactivated polio vaccine or non OPV in endemic areas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Taylor S, Shimp L (2010) Using data to guide action in polio health communications: experience from the polio eradication initiative (PEI). J Health Commun 15(S1):48–65

    Article  PubMed  Google Scholar 

  2. Arora NK, Chaturvedi S, Dasgupta R (2010) Global lessons from India’s poliomyelitis elimination campaign. Bull World Health Organ 88(3):232–234

    Article  PubMed  Google Scholar 

  3. Pallansch MA, Sandhu HS (2006) The eradication of polio—progress and challenges. N Engl J Med 355(24):2508–2511

    Article  PubMed  CAS  Google Scholar 

  4. Shah NK, John TJ, Thacker N et al (2006) Polio eradication strategies in India: recommendations under IAP action plan 2006. Indian Pediatr 43(12):1057–1063

    PubMed  Google Scholar 

  5. Paul Y (2005) Polio eradication programme: some ethical issues. Indian J Med Ethics 2(4):115–116

    PubMed  Google Scholar 

  6. Patriarca PA, Wright PF, John TJ (1991) Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 13(5):926–939

    Article  PubMed  CAS  Google Scholar 

  7. Skern T (2010) 100 years poliovirus: from discovery to eradication. A meeting report. Arch Virol 155(9):1371–1381

    Article  PubMed  CAS  Google Scholar 

  8. Chaturvedi G (2008) The vital drop: communication for polio eradication in India. Sage Publications Pvt Ltd, New Delhi

    Google Scholar 

  9. Yotsu RR (2008) Global priorities and local realities: exploring what happens to children identified with acute flaccid. University of Liverpool

  10. Grassly NC, Jafari H, Bahl S et al (2009) Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India. J Infect Dis 200(5):794–801

    Article  PubMed  Google Scholar 

  11. John T, Jain H, Ravishankar K, et al (2011) Monovalent type 1 oral poliovirus vaccine among infants in India: Report of two randomized double-blind controlled clinical trials. Vaccine 5(29/34):5793–5801

    Google Scholar 

  12. De Jesus NH (2007) Epidemics to eradication: the modern history of poliomyelitis. Virol J 4:70. doi:10.1186/1743-422X-4-70

  13. Martin J (2011) Detection and characterization of polioviruses. Methods Mol Biol (Clifton) 665:233

    Article  CAS  Google Scholar 

  14. Barrett S (2009) Polio eradication: strengthening the weakest links. Health Aff (Millwood) 28(4):1079–1090

    Article  Google Scholar 

  15. Sutter RW, Tangermann RH, Aylward RB et al (2001) Poliomyelitis eradication: progress, challenges for the end game, and preparation for the post-eradication era. Infect Dis Clin North Am 15(1):41–64

    Article  PubMed  CAS  Google Scholar 

  16. Faraj AA (2006) Poliomyelitis: orthopaedic management. Curr Orthop 20(1):41–46

    Article  Google Scholar 

  17. Mukherji WCS, Jindal LCAK, Singh BZ et al (2005) Polio eradication in India: myth or reality. Med J Arm Forces Ind 61(4):364–366

    Article  Google Scholar 

  18. Sathyamala C, Mittal O, Dasgupta R et al (2005) Polio eradication initiative in India: deconstructing the GPEI. Int J Health Serv 35(2):361–383

    Article  PubMed  CAS  Google Scholar 

  19. Andrus JK, Thapa AB, Withana N et al (2001) A new paradigm for international disease control: lessons learned from polio eradication in Southeast Asia. Am J Public Health 91(1):146–150

    Article  PubMed  CAS  Google Scholar 

  20. Vashishtha VM (2009) Polio eradication in India: need for caution. Indian J Pediatr 76(7):757

    Article  PubMed  Google Scholar 

  21. Paul Y (2007) Role of genetic factors in polio eradication: new challenge for policy makers. Vaccine 25(50):8365–8371

    Article  PubMed  Google Scholar 

  22. Heymann DL, Sutter RW, Aylward RB (2006) A vision of a world without polio: the OPV cessation strategy. Biologicals 34(2):75–79

    Article  PubMed  Google Scholar 

  23. Blume SS (2005) Lock in, the state and vaccine development: lessons from the history of the polio vaccines. Res Policy 34(2):159–173

    Article  Google Scholar 

  24. Modlin JF (2010) The bumpy road to polio eradication. N Engl J Med 362(25):2346–2349

    Article  PubMed  CAS  Google Scholar 

  25. Heymann DL, Sutter RW, Aylward RB (2006) Polio eradication: interrupting transmission, towards a polio-free world. Future Virol 1(2):181–188

    Article  Google Scholar 

  26. Estívariz CF, Molnár Z, Venczel L et al (2011) Paralytic poliomyelitis associated with sabin monovalent and bivalent oral polio vaccines in Hungary. Am J Epidemiol 174(3):316–325

    Article  PubMed  Google Scholar 

  27. Ehrenfeld E, Modlin J, Chumakov K (2009) Future of polio vaccines. Expert Rev Vaccines 8(7):899–905

    Article  PubMed  Google Scholar 

  28. Vashishtha VM, Kalra A, Jacob John T et al (2010) Recommendations of national consultative meeting on polio eradication, 2010; polio eradication committee, Indian academy of pediatrics (IAP). Indian Pediatr 47(9):749–751

    Article  PubMed  Google Scholar 

  29. Baldwin SL, Fox CB, Pallansch MA et al (2010) Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions. Vaccine 29(4):644–649

    Article  PubMed  Google Scholar 

  30. Henriksen M (2011) Formulation and development of cationic liposomes as adjuvants for subunit protein vaccinese. PhD Thesis, Aston University

  31. Bramwell VW, Perrie Y (2005) The rational design of vaccines. Drug Discov Today 10(22):1527–1534

    Article  PubMed  CAS  Google Scholar 

  32. Chumakov K, Ehrenfeld E, Plotkin S (2008) New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis. Clin Infect Dis 47(12):1587–1592

    Article  PubMed  Google Scholar 

  33. Paul Y (2009) Oral polio vaccines and their role in polio eradication in India. Exp Rev Vaccines 8(1):35–41

    Article  Google Scholar 

  34. Paul Y (2008) OPV cannot eradicate polio from India: do we need any further evidence? Vaccine 26(17):2058–2061

    Article  PubMed  Google Scholar 

  35. Kidd S (2009) Progress toward poliomyelitis eradication—India, January 2007-May 2009. Morb Mortal Wkly Rep 58(26):719–723

    Google Scholar 

  36. Chandra R (1975) Reduced secretory antibody response to live attenuated measles and poliovirus vaccines in malnourished children. Br Med J 2(5971):583–585

    Article  PubMed  CAS  Google Scholar 

  37. Paul Y (2009) Why polio has not been eradicated in India despite many remedial interventions? Vaccine 27(28):3700–3703

    Article  PubMed  Google Scholar 

  38. Savolainen Kopra C, Blomqvist S (2010) Mechanisms of genetic variation in polioviruses. Rev Med Virol 20(6):358–371

    Article  PubMed  Google Scholar 

  39. Yakovenko ML, Korotkova EA, Ivanova OE et al (2009) Evolution of the Sabin vaccine into pathogenic derivatives without appreciable changes in antigenic properties: need for improvement of current poliovirus surveillance. J Virol 83(7):3402

    Article  PubMed  CAS  Google Scholar 

  40. Thomas ES (2010) Investigating the impact of polio vaccines and vaccine-derived polioviruses (VDPVs) on the global effort to eradicate polio. Washington College

  41. WHO (2011) Tracking progress toward global polio eradication—worldwide, 2009–2010. J Am Med Assoc 305(21):2165–2167

    Google Scholar 

  42. Kew O (2006) What role for inactivated poliovirus vaccine in the eradication endgame? J Infect Dis 193(10):1341–1343

    Article  PubMed  Google Scholar 

  43. Doshi SJ, Sandhu HS, Venczel LV et al (2011) Poliomyelitis-related case-fatality ratio in India, 2002–2006. Clin Infect Dis 53(1):13–19

    Article  PubMed  Google Scholar 

  44. Zhou W, Pool V, Iskander JK et al (2003) Surveillance for safety after immunization: vaccine adverse event reporting system (VAERS)—United States, 1991–2001. MMWR Surveill Summ 52(1):1–24

    PubMed  Google Scholar 

  45. Chezzi C, Dommann C, Blackburn N et al (1998) Genetic stability of oral polio vaccine prepared on primary monkey kidney cells or Vero cells—effects of passage in cell culture and the human gastrointestinal tract. Vaccine 16(20):2031–2038

    Article  PubMed  CAS  Google Scholar 

  46. Horie H, Miyazawa M, Ota Y et al (2001) Analysis of the accumulation of mutants in Sabin attenuated polio vaccine viruses passaged in Vero cells. Vaccine 19(11–12):1456–1459

    Article  PubMed  CAS  Google Scholar 

  47. Asia UNS (2003) A critical leap to polio eradication in India. Kathmandu: United Nations Children’s Fund Regional Office for South Asia. 1–84

  48. Furesz J (2006) Developments in the production and quality control of poliovirus vaccines—historical perspectives. Biologicals 34(2):87–90

    Article  PubMed  CAS  Google Scholar 

  49. Salk J (1979) Immunization against poliomyelitis: risk/benefit/cost in a changing context. Dev Biol Stand 43:151–157

    PubMed  CAS  Google Scholar 

  50. Lewis JA (2011) Production of polio virus at high titers for vaccine production. WO Patent WO/2011/006,823

  51. Prevots D, Burr R, Sutter R, Murphy T (2000) Advisory committee on immunization practices. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 49:1–22

    Google Scholar 

  52. Neutra MR, Kozlowski PA (2006) Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6(2):148–158

    Article  PubMed  CAS  Google Scholar 

  53. Finn A, Bell F (1998) Polio vaccine: is it time for a change? Arch Dis Child 78(6):571–574

    Article  PubMed  CAS  Google Scholar 

  54. Dayan GH, Thorley M, Yamamura Y et al (2007) Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico. J Infect Dis 195(1):12–20

    Article  PubMed  Google Scholar 

  55. Modlin JF, Halsey NA, Thoms ML et al (1997) Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. J Infect Dis 175(1):S228–S2234

    Article  PubMed  Google Scholar 

  56. Resik S, Tejeda A, Mas Lago P et al (2010) Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba. J Infect Dis 201(9):1344–1352

    Article  PubMed  Google Scholar 

  57. Mohammed AJ, AlAwaidy S, Bawikar S et al (2010) Fractional doses of inactivated poliovirus vaccine in Oman. N Engl J Med 362(25):2351–2359

    Article  PubMed  CAS  Google Scholar 

  58. Hickling J, Jones K, Friede M et al (2011) Intradermal delivery of vaccines: potential benefits and current challenges. Bull World Health Organ 89(3):221–226

    Article  PubMed  CAS  Google Scholar 

  59. Vashishtha VM, Kalra A, John TJ et al (2010) Recommendations of national consultative meeting on polio eradication, 2010; polio eradication committee, Indian academy of pediatrics (IAP). Indian Pediatr 47:749–751

    Article  PubMed  Google Scholar 

  60. Semler BL (2004) Poliovirus proves IRES-istible in vivo. J Clin Invest 113(12):1678–1680

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

    T. N. Dhole & Vikas Mishra

Authors
  1. T. N. Dhole
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vikas Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. N. Dhole.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dhole, T.N., Mishra, V. Polio Eradication in India. Proc. Natl. Acad. Sci. Sect B. Biol. Sci. 82, 123–133 (2012). https://doi.org/10.1007/s40011-011-0010-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40011-011-0010-0

Keywords

Search

Navigation